The relationship between amyloid pathology, cerebral small vessel disease, glymphatic dysfunction, and cognition: a study based on Alzheimer’s disease continuum participants
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The relationship between amyloid pathology, cerebral small vessel disease, glymphatic dysfunction, and cognition: a study based on Alzheimer’s disease continuum participants ; volume:16 ; number:1 ; day:20 ; month:2 ; year:2024 ; pages:1-13 ; date:12.2024
Alzheimer's research & therapy ; 16, Heft 1 (20.2.2024), 1-13, 12.2024
- Classification
-
Medizin, Gesundheit
- Creator
-
Hong, Hui
Hong, Luwei
Luo, Xiao
Zeng, Qingze
Li, Kaicheng
Wang, Shuyue
Jiaerken, Yeerfan
Zhang, Ruiting
Yu, Xinfeng
Zhang, Yao
Lei, Cui
Liu, Zhirong
Chen, Yanxing
Huang, Peiyu
Zhang, Minming
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-024-01407-w
- URN
-
urn:nbn:de:101:1-2404291046236.273038163374
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hong, Hui
- Hong, Luwei
- Luo, Xiao
- Zeng, Qingze
- Li, Kaicheng
- Wang, Shuyue
- Jiaerken, Yeerfan
- Zhang, Ruiting
- Yu, Xinfeng
- Zhang, Yao
- Lei, Cui
- Liu, Zhirong
- Chen, Yanxing
- Huang, Peiyu
- Zhang, Minming
- SpringerLink (Online service)
Other Objects (12)
Updates in Alzheimer's disease: from basic research to diagnosis and therapies
Zeichen- und Wortschatz des Chinesischen effizienter lernen: Konzeption einer Lernwörter-App für deutsche ChaF-Lernende auf der Basis einer empirischen Bedarfsanalyse
Glial activation and inflammation along the Alzheimer’s disease continuum
Alzheimer’s Disease
Melatonin levels in the Alzheimer’s disease continuum: a systematic review
On the path to 2025: understanding the Alzheimer’s disease continuum
Alzheimer's disease
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
Alterations in resting-state network dynamics along the Alzheimer’s disease continuum
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Updates in Alzheimer's disease: from basic research to diagnosis and therapies
Zeichen- und Wortschatz des Chinesischen effizienter lernen: Konzeption einer Lernwörter-App für deutsche ChaF-Lernende auf der Basis einer empirischen Bedarfsanalyse
Glial activation and inflammation along the Alzheimer’s disease continuum
Alzheimer’s Disease
Melatonin levels in the Alzheimer’s disease continuum: a systematic review
On the path to 2025: understanding the Alzheimer’s disease continuum
Alzheimer's disease
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
Alterations in resting-state network dynamics along the Alzheimer’s disease continuum
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Updates in Alzheimer's disease: from basic research to diagnosis and therapies
Zeichen- und Wortschatz des Chinesischen effizienter lernen: Konzeption einer Lernwörter-App für deutsche ChaF-Lernende auf der Basis einer empirischen Bedarfsanalyse
Glial activation and inflammation along the Alzheimer’s disease continuum
Alzheimer’s Disease
Melatonin levels in the Alzheimer’s disease continuum: a systematic review
On the path to 2025: understanding the Alzheimer’s disease continuum
Alzheimer's disease
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
Alterations in resting-state network dynamics along the Alzheimer’s disease continuum
Disease-modifying treatments in Alzheimer’s disease